Comprehensive Research Finds That TRT is Unrelated to Adverse CV Events
Recent clinical studies have found that there is no causative link between Testosterone Replacement Therapy (TRT) and an increased risk of cardiovascular (CV) adverse outcomes.
The pharmacoepidemiological conclusions published in the Expert Review of Cardiovascular Therapy sought to deliver scientific clarity on the subject, given conflicting findings garnered from previous reports.
TRT & CV: Research Leaves No Stone Unturned
The clinical review, led by Giovanni Corona, MD, Azienda Usl Bologna Maggiore-Bellaria Hospital, Bologna, Italy, was a comprehensive undertaking. His team conducted a statistical and systematic analysis of the collective data from 31 randomized, clinically controlled trials published between 2010 – 2018.
The breakthrough takeaway from this intensive study? Testosterone Replacement Therapy was found to be unrelated to adverse cardiovascular events.
NuLife Institute is transforming the lives of men suffering from Low T and issues relating to testosterone deficiency. Could you benefit from one of our bespoke programs? Call now to speak with our team of experts at (305) 400-0005 and learn how much we can do for you.
Untreated, testosterone deficiency syndrome can lead to symptoms including:
NuLife Institute: Pioneers and Leaders in TRT
As one of the leading providers of TRT in Miami, Nulife Institute’s physicians are experts in assessing the precise hormonal needs of every patient on an individual basis.
Our thorough and methodical approach means that we can customize a TRT package that is tailored to your specific requirements for optimized results.
Call today at (305) 400-0015 to arrange a free consultation with our specialist medical team and find out more.